Company: Aurobindo Pharma Ltd. Category: IPO Notes


NULL
May 29, 2019, 10:46 a.m.
Publisher: moneycontrol.com

NULL
Feb. 8, 2019, 11:04 a.m.
Publisher: moneycontrol.com

For Lupin, Credit Suisse sees margin improving but weak Tamiflu season could be an overhang.
Jan. 4, 2019, 10:45 a.m.
Publisher: moneycontrol.com

NULL
Nov. 12, 2018, 7:17 p.m.
Publisher: moneycontrol.com


The earnings before interest, taxes, depreciation and amortization was reported at Rs 986.3 crore for the September quarter.
Nov. 12, 2018, 7:07 p.m.
Publisher: moneycontrol.com

Further, high RD cost is likely to affect financials as well, one brokerage house wrote in its report.
Nov. 12, 2018, 8:18 a.m.
Publisher: moneycontrol.com

Net Sales are expected to decrease by 3.9 percent Y-o-Y (up 0.3 percent Q-o-Q) to Rs. 4,260 crore, according to HDFC Securities.
Oct. 17, 2018, 5:39 p.m.
Publisher: moneycontrol.com

Net Sales are expected to increase by 6.3 percent Y-o-Y (up 10.9 percent Q-o-Q) to Rs. 4,714 crore, according to Sharekhan.
Oct. 16, 2018, 6:55 p.m.
Publisher: moneycontrol.com

Net Sales are expected to increase by 4.6 percent Y-o-Y (up 9.1 percent Q-o-Q) to Rs. 4,638.9 crore, according to ICICI Direct.
Oct. 12, 2018, 3:54 p.m.
Publisher: moneycontrol.com

Centrum bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1010 in its research report dated August 13, 2018.
Aug. 20, 2018, 5:43 p.m.
Publisher: moneycontrol.com

-->